Semaglutide (Ozempic, Wegovy, Rybelsus) effectively manages type 2 diabetes and supports weight loss by reducing appetite and delaying gastric emptying
Mid-morning or early afternoon snacks featuring peanut butter can be particularly effective on days when you need to maintain energy levels but feel limited appetite
Its active ingredient, semaglutide, belongs to a class of drugs known as GLP-1 receptor agonists
However, very few studies have evaluated the impact of GLP-1 receptor agonists on eye health
Most patients are microdosing due to the following reasons: Mitigating side effects Semaglutide is associated with various side effects like nausea, vomiting, abdominal pain, diarrhea, and constipation
Failure to Warn Allegations in Ozempic Lawsuits The lawsuits surrounding Novo Nordisk, the manufacturer of Ozempic, have brought significant attention to the concept of failure to warn. At the core of these legal claims, plaintiffs argue that the company did not adequately inform consumers about the risks of gallbladder complications, including gallstones and acute gallbladder disease, associated with their medication
